Blue Goat Cyber

Blue Goat Cyber Blue Goat Cyber is a leading consultancy specializing in medical device cybersecurity.

We provide expert medical device cybersecurity services, specializing in FDA premarket submissions, postmarket management, risk management, threat modeling, secure development, and regulatory compliance, focused on patient safety and compliance. Founded by Christian Espinosa, a recognized expert in the field, our company provides comprehensive cybersecurity solutions tailored to the unique needs of medical device manufacturers. With a deep understanding of both regulatory requirements and the evolving threat landscape, Blue Goat Cyber is your trusted partner in navigating the complexities of FDA premarket submissions and postmarket management. At Blue Goat Cyber, we excel at simplifying complex cybersecurity challenges, ensuring that your devices not only meet stringent regulatory standards but also operate securely throughout their lifecycle. Our team combines extensive industry experience with cutting-edge cybersecurity practices to deliver customized strategies that mitigate risks and enhance device security. Whether you’re preparing for an FDA submission, conducting threat modeling, or managing postmarket surveillance, Blue Goat Cyber offers the expertise and support you need to protect your devices and patients. Our mission is to empower medical device manufacturers with the knowledge and tools to achieve robust cybersecurity, ensuring patient safety and regulatory compliance at every stage.

A product manager approves a ""minor"" library bump. Engineering ships it. Six months later, nobody can explain why the ...
10/04/2026

A product manager approves a ""minor"" library bump. Engineering ships it. Six months later, nobody can explain why the postmarket monitoring record doesn't match what's actually deployed.

That gap isn't a cybersecurity failure. It's a quality system failure, and it's exactly why threat models, SBOMs, and VEX statements now have to live inside the QMS with the same change control as every other device record.

The article names the documents most teams create too late.

Discover what belongs in your QMS: https://bluegoatcyber.com/blog/cybersecurity-qms-documentation-medtech

A passing pen test report can feel like a finish line. It's actually a snapshot.A specialized API pe*******on test on a ...
10/03/2026

A passing pen test report can feel like a finish line. It's actually a snapshot.

A specialized API pe*******on test on a medical device finds high-impact issues automated tools miss: broken object-level authorization, privilege escalation into admin endpoints, weak rate-limiting, and injection flaws. But that snapshot only reflects one build on one day, and it can't fix a flaw sitting in the underlying security architecture itself.

Key takeaway: A clean pen test proves your API held up on test day, not that it always will.

What questions do you have about API security or medical device pe*******on testing?

A hospital room quietly protects a medical device in ways most manufacturers never have to think about.Network segmentat...
10/02/2026

A hospital room quietly protects a medical device in ways most manufacturers never have to think about.

Network segmentation, badge access, and a biomed team on call all absorb risk before it ever reaches the device. Move that same device into a patient's living room, and every one of those protections disappears.

The full piece gets into what a device has to carry on its own once it leaves the clinic, and why claiming both environments means designing to the weaker one.

Learn how use environment reshapes your threat model: https://bluegoatcyber.com/blog/home-use-vs-hospital-device-cybersecurity

10/01/2026

Cybersecurity can enter a medical device's development at very different moments.

Some teams shape the architecture around security requirements from the earliest design sketches. Others build the core functionality first and add protective layers once the design is largely locked in.

🏗️ Build security into the architecture from day one

OR

🔧 Layer protections onto a design that's already set

Both paths can lead to a cleared device. Only one tends to cost less along the way.

Where does your organization actually operate, and where would you like to be?

You can’t talk about the future of MedTech without talking about cybersecurity.That’s one of the conversations Blue Goat...
10/01/2026

You can’t talk about the future of MedTech without talking about cybersecurity.

That’s one of the conversations Blue Goat Cyber is bringing to MedTech World Europe 2026, where we’ll be joining the global MedTech community as a Title Sponsor.

As devices become more connected, software driven, and AI enabled, cybersecurity touches far more than regulatory compliance. It influences product development, patient safety, market access, and the long term resilience of the technology.

This November, those conversations are coming to Malta.

Meet the Goats at MedTech World Europe, November 11–13.

09/30/2026

MYTH: An SBOM is just a list you create for a regulatory submission.

REALITY: Its value extends well beyond the submission itself.

A Software Bill of Materials provides visibility into the software components contained within a device.

That becomes particularly valuable after the product reaches the market. When a new vulnerability is disclosed, manufacturers can use component information to help determine whether their devices may be affected.

An SBOM isn't simply documentation of what's in the device today. It can become an important resource for understanding tomorrow's vulnerabilities.

Not every cybersecurity vulnerability carries the same level of risk.CVSS provides a standardized framework for describi...
09/28/2026

Not every cybersecurity vulnerability carries the same level of risk.

CVSS provides a standardized framework for describing the severity of vulnerabilities based on characteristics such as how they can be exploited and what impact exploitation could have.

Scores range from 0.0 to 10.0, with higher scores representing greater technical severity.

But there is an important distinction in MedTech: vulnerability severity and patient safety risk are not automatically the same thing.

A number can help inform the conversation, but it doesn't tell the entire story.

An FDA cybersecurity submission is only as strong as the evidence behind it.For cyber devices, manufacturers need to dem...
09/27/2026

An FDA cybersecurity submission is only as strong as the evidence behind it.

For cyber devices, manufacturers need to demonstrate how cybersecurity has been addressed across the product lifecycle. That includes a documented SPDF, threat modeling, a machine-readable SBOM, security testing, cybersecurity labeling, and a postmarket plan.

The challenge is making sure those artifacts tell a consistent story and trace identified threats through mitigations and verification.

Preparing for a 510(k), De Novo, or PMA? Use this premarket cybersecurity checklist to see what should be in place before submission.
https://bluegoatcyber.com/blog/premarket-fda-cybersecurity-submission-checklist

For cyber devices, FDA reviewers want to see that cybersecurity was considered throughout the device lifecycle, not adde...
09/26/2026

For cyber devices, FDA reviewers want to see that cybersecurity was considered throughout the device lifecycle, not added at the end.

A strong submission should show how the device was designed, tested, and prepared for real-world cybersecurity risks. That may include a threat model, SBOM, vulnerability analysis, cybersecurity architecture, security testing, pe*******on testing, and a postmarket plan.

The strongest submissions also show how threats connect to controls, risk assessments, and patient safety.

Key takeaway: A clear cybersecurity story helps reviewers understand how risks were identified, addressed, and managed.

Have a question about preparing your device for FDA review?
https://bluegoatcyber.com/ask-the-goat

Every Pre-Sub is a Q-Sub, but not every Q-Sub is a Pre-Sub.It’s a small distinction that can create plenty of confusion ...
09/25/2026

Every Pre-Sub is a Q-Sub, but not every Q-Sub is a Pre-Sub.

It’s a small distinction that can create plenty of confusion for medical device teams.

A Q-Sub refers to the broader FDA program for premarket interactions, while a Pre-Sub is the pathway manufacturers can use to request feedback on specific questions before submitting a 510(k), De Novo, or PMA.

For cybersecurity, that feedback can be particularly useful when your team is navigating novel architecture, threat model scope, SBOM depth, pe*******on testing methodology, or PCCP decisions.

Get clarity on the terminology and learn when a cybersecurity Pre-Sub may be worth considering. https://bluegoatcyber.com/blog/q-sub-vs-pre-sub-fda-cybersecurity

Address

1776 North Scottsdale Road, Unit 727
Scottsdale, AZ
82527

Telephone

+13073178884

Website

Alerts

Be the first to know and let us send you an email when Blue Goat Cyber posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Blue Goat Cyber:

Shortcuts

Share

Category